(Q71859536)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605662%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Radiotherapy alone for non-small cell lung carcinoma. Five-year disease-free survival and patterns of failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605662%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Radiotherapy Alone for Non-Small Cell Lung Carcinoma Five-year disease-free survival and patterns of failure (English)

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

10 June 2024

author name string

M. Koukourakis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7605662

10 June 2024

J. Skarlatos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7605662

10 June 2024

L. Kosma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7605662

10 June 2024

A. Giatromanolaki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7605662

10 June 2024

D. Yannakakis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7605662

10 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7605662

10 June 2024

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605662%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605662%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605662%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605662%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

525-530

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605662%20AND%20SRC:MED&resulttype=core&format=json

Interpreting cancer survival rates

21 October 2019

cites work

3

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

Controversies in the management of non-small cell lung cancer: the results of an expert surrogate study

10 June 2024

4

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

10 June 2024

5

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

Inoperable non-small cell lung cancer: radiation with or without chemotherapy

10 June 2024

6

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer

10 June 2024

7

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

Curative radiotherapy of early operable non-small cell lung cancer

10 June 2024

9

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer

10 June 2024

10

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx

10 June 2024

12

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

Curative radiotherapy in non-small cell carcinoma of the lung

10 June 2024

15

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

Total atelectasis of the lung secondary to malignant airway obstruction. Response to radiation therapy.

10 June 2024

16

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

Concomitant 5-fluorouracil infusion and high-dose radiation for stage III non-small cell lung cancer

10 June 2024

17

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

How worthwhile are short schedules in radiotherapy? A series of exploratory calculations

10 June 2024

19

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus

10 June 2024

20

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

10 June 2024

21

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 GY by the radiation therapy oncology group

10 June 2024

22

1 reference

https://api.crossref.org/works/10.3109/02841869509094018

10 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605662%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference